Monday, July 20, 2015

Richmond Pharmacology update

Here is a quick note about yesterday's hearing. Judgment is expected next week. 

The judge grasped the importance of trial registration and when he took into account our and the HRA's evidence on legal and ethical obligations to register trials he found that Richmond was left with an extraordinarily narrow argument. It seems the case will come down to some words in a Q&A on HRA's website that wasn't amended at the same time as the sponsors' declaration was. And then whether the ambiguity was significant.

We are so pleased we decided to intervene in the case. The court could find for Richmond on this very narrow point but it ended up exactly where we thought it should be: a principled discussion in which the judge seemed to grasp the issues well, the removal of Richmond’s broad claims that no registration was legally required and that the HRA was acting unlawfully, and alighting on a narrow matter for decision that will not impact on how trials are run or on the EU rules coming into force next year. Of course we would have liked the case refused altogether instead of it wasting public funds, which will be a lot if HRA has to pay Richmond's costs. 

Based on what was said in court, we are hopeful too that the court will find that the HRA has been going about its proper business promoting clinical trial registration. We are pleased that the judge ignored Richmond's attempts to discredit AllTrials, and in fact that these appeared to backfire.

We will share the transcript of yesterday's hearing as soon as we have it. I think you'll enjoy reading it! 

When the judge at the hearing yesterday heard that the HRA does not impose any sanctions on trial sponsors who don't register their trials properly he said, "well, they should." 

Our legal team was amazing - solicitor Robert Dougans and barrister Jonathan Price - before during and after. If any of you read L Phillips' recent speech asking where are the lawyers who are motivated above all by the pursuit of justice, well we know them. 

(Tracey Brown is especially grateful for their patience with her unceasing flow of notes and questions) 

Also yesterday, the pharmaceutical industry body EMIG said that Richmond's actions do not represent the views of the rest of industry. Mark Edwards, the CEO, said that the case could have a disastrous effect on the industry. Read EMIGs letter here. It contradicts Richmond's claim to the court that its concerns are representative. Some of you have told us that but EMIG said it publicly, which matters. 

Thank you so much to those who came to court yesterday and sent messages of support. As well as the judgment, look out for some other big news stories from AllTrials next week: we can't wait to tell you what your support has helped to achieve.



Síle Lane

Director of Campaigns

Sense About Science

Science and evidence in the hands of the public |@senseaboutsci

No comments: